Using the TIME-EMS as a testing model, our data provided the long-sought-after evidence of TAM cross-priming and activating TILs and the results are consistent with the idea of pre-existing pools of tumor-specific CD8 T cells in the TME.3 Here, CD8A is linked to neoplasm.